Treatment of spasticity.
Rösche
J
J
D000085:Acetates / Q000627:therapeutic use; D000588:Amines; D000631:Aminopyridines / Q000627:therapeutic use; D001418:Baclofen / Q000627:therapeutic use; D001569:Benzodiazepines; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003000:Clonidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D006801:Humans; D008559:Memantine / Q000627:therapeutic use; D009128:Muscle Spasticity / Q000628:therapy; D010243:Paralysis / Q000628:therapy*; D019051:Rhizotomy; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000631:Aminopyridines; D003509:Cyclohexanecarboxylic Acids; D001569:Benzodiazepines; D005680:gamma-Aminobutyric Acid; C023754:tizanidine; D000077206:Gabapentin; D019274:Botulinum Toxins, Type A; D001418:Baclofen; D003000:Clonidine; C034161:flupirtine; D008559:Memantine